Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of a comprehensive geriatric assessment to manage elderly patients with locally advanced non-small-cell lung cancers: An open phase II study using concurrent cisplatin-oral vinorelbine and radiotherapy (GFPC 08-06).
Locher C, Pourel N, Le Caer H, Berard H, Auliac JB, Monnet I, Descourt R, Vergnenègre A, Lafay IM, Greillier L, Chouaïd C. Locher C, et al. Among authors: vergnenegre a. Lung Cancer. 2018 Jul;121:25-29. doi: 10.1016/j.lungcan.2018.04.017. Epub 2018 Apr 22. Lung Cancer. 2018. PMID: 29858022 Clinical Trial.
Randomized multicentric phase II study of carboplatin/gemcitabine and cisplatin/vinorelbine in advanced non-small cell lung cancer GFPC 99-01 study (Groupe français de pneumo-cancérologie).
Thomas P, Robinet G, Gouva S, Fournel P, Léna H, Le Caer H, Perol M, Berard H, Bombaron P, Vergnenegre A, Kleisbauer JP; Groupe français de pneumo-cancérologie. Thomas P, et al. Among authors: vergnenegre a. Lung Cancer. 2006 Jan;51(1):105-14. doi: 10.1016/j.lungcan.2005.10.004. Epub 2005 Nov 28. Lung Cancer. 2006. PMID: 16310886 Clinical Trial.
[A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)].
Locher C, Pourel N, Marin B, Vergnenègre A; et le GFPC. Locher C, et al. Among authors: vergnenegre a. Rev Mal Respir. 2011 Jan;28(1):58-65. doi: 10.1016/j.rmr.2010.04.019. Epub 2011 Jan 11. Rev Mal Respir. 2011. PMID: 21277475 Clinical Trial. French.
A multicentre phase II randomised trial of weekly docetaxel/gemcitabine followed by erlotinib on progression, vs the reverse sequence, in elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0504 study).
LeCaer H, Barlesi F, Corre R, Jullian H, Bota S, Falchero L, Vergnenegre A, Dujon C, Delhoume JY, Chouaid C; GFPC 0504 Team. LeCaer H, et al. Among authors: vergnenegre a. Br J Cancer. 2011 Oct 11;105(8):1123-30. doi: 10.1038/bjc.2011.331. Epub 2011 Sep 20. Br J Cancer. 2011. PMID: 21934690 Free PMC article. Clinical Trial.
A multicenter phase II randomized trial of gemcitabine followed by erlotinib at progression, versus the reverse sequence, in vulnerable elderly patients with advanced non small-cell lung cancer selected with a comprehensive geriatric assessment (the GFPC 0505 study).
LeCaer H, Greillier L, Corre R, Jullian H, Crequit J, Falchero L, Dujon C, Berard H, Vergnenegre A, Chouaid C; GFPC 0505 Team. LeCaer H, et al. Among authors: vergnenegre a. Lung Cancer. 2012 Jul;77(1):97-103. doi: 10.1016/j.lungcan.2012.02.004. Epub 2012 Mar 8. Lung Cancer. 2012. PMID: 22405570 Clinical Trial.
Cost effectivenes of erlotinib versus chemotherapy for first-line treatment of non small cell lung cancer (NSCLC) in fit elderly patients participating in a prospective phase 2 study (GFPC 0504).
Chouaid C, Le Caer H, Locher C, Dujon C, Thomas P, Auliac JB, Monnet I, Vergnenegre A; GFPC 0504 Team. Chouaid C, et al. Among authors: vergnenegre a. BMC Cancer. 2012 Jul 20;12:301. doi: 10.1186/1471-2407-12-301. BMC Cancer. 2012. PMID: 22817667 Free PMC article. Clinical Trial.
Randomized open-label non-comparative multicenter phase II trial of sequential erlotinib and docetaxel versus docetaxel alone in patients with non-small-cell lung cancer after failure of first-line chemotherapy: GFPC 10.02 study.
Auliac JB, Chouaid C, Greillier L, Monnet I, Le Caer H, Falchero L, Corre R, Descourt R, Bota S, Berard H, Schott R, Bizieux A, Fournel P, Labrunie A, Marin B, Vergnenegre A; GFPC team. Auliac JB, et al. Among authors: vergnenegre a. Lung Cancer. 2014 Sep;85(3):415-9. doi: 10.1016/j.lungcan.2014.07.006. Epub 2014 Jul 17. Lung Cancer. 2014. PMID: 25082565 Clinical Trial.
Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14.
Auliac JB, Bayle S, Vergnenegre A, Le Caer H, Falchero L, Gervais R, Doubre H, Vinas F, Marin B, Chouaid C. Auliac JB, et al. Among authors: vergnenegre a. Curr Oncol. 2018 Oct;25(5):e398-e402. doi: 10.3747/co.25.3945. Epub 2018 Oct 31. Curr Oncol. 2018. PMID: 30464690 Free PMC article.
189 results